BioDelivery Sciences International, Inc. (BDSI) Comparison with companies in other sectors?

BioDelivery Sciences International, Inc. has a share price of 103.23M. You can analyze BioDelivery Sciences International, Inc. (BDSI) competitors across different market sectors through stock heatmaps.

What are BDSI's NET and operating margins?

BioDelivery Sciences International, Inc. (BDSI) operating margin is around 0.22, and net profit margin is approximately 0.51 as of the latest reports.

In what way does BDSI's earnings per share (EPS) trend reflect its financial momentum?

BioDelivery Sciences International, Inc. (BDSI) EPS is 0.82 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for BioDelivery Sciences International, Inc. is 6.82, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for BioDelivery Sciences International, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for BioDelivery Sciences International, Inc. like P/E which is 6.80, P/B which is 3.07, and PEG which is 0.07. Compare them with sector averages to evaluate if the stock is priced fairly.

BioDelivery Sciences International, Inc.

BDSI•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$5.59

$-0.00(-0.09%)

Fundamental Analysis of BioDelivery Sciences International, Inc. (BDSI)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.82

P/E Ratio

6.82

ROE

0.57%

Net Margin

0.51%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$577.05M

Shares OutstandingTotal number of shares issued

$103.23M

Book Value/ShareNet worth per share

$1.82

Revenue/ShareAnnual revenue per share

$1.61

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.82

Net MarginNet income as percentage of revenue

50.90%

Operating MarginOperating income as percentage of revenue

22.27%

ROEReturn on shareholders' equity

57.33%

ROAReturn on total assets

26.14%

ROCEReturn on capital employed

15.33%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.39

Cash/ShareCash and equivalents per share

$1.11

FCF YieldFree cash flow as percentage of market cap

7.04%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BDSIFinancial Ratios Analysis details for BDSI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BDSISector Benchmarking details for BDSI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for BioDelivery Sciences International, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of BioDelivery Sciences International, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account BioDelivery Sciences International, Inc.'s unique business strengths and challenges.

Key Financial Metrics for BioDelivery Sciences International, Inc.

For BioDelivery Sciences International, Inc., essential financial indicators include EPS 0.82, PE 6.82, and ROE 0.57. These key ratios reveal insights into BioDelivery Sciences International, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare BioDelivery Sciences International, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of BioDelivery Sciences International, Inc.

Metrics like Net Margin 50.90% and ROA 26.14% shed light on how well BioDelivery Sciences International, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether BioDelivery Sciences International, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of BioDelivery Sciences International, Inc.

Using ratios such as P/B Ratio 3.07 and PEG Ratio 0.07, investors can assess whether BioDelivery Sciences International, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with BioDelivery Sciences International, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for BioDelivery Sciences International, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.31 and Cash Flow $0.39, provide a snapshot of BioDelivery Sciences International, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like BioDelivery Sciences International, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for BioDelivery Sciences International, Inc.

Investing in BioDelivery Sciences International, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at BioDelivery Sciences International, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;